Valsalva视网膜病变的玻璃体手术治疗  

Vitrectomy with internal limiting membrane peeling for Valsalva retinopathy

作　　者：雷少波[1] 唐罗生[1] 朱晓华[1] 郭小健[1] 

机构地区：[1]中南大学湘雅二医院眼科,中国湖南省长沙市410011

出　　处：《国际眼科杂志》2008年第7期1469-1470,共2页International Eye Science

摘　　要：目的：探讨玻璃体切除联合内界膜剥除术对Valsalva视网膜病变的疗效与安全性。方法：对因Valsalva视网膜病变接受玻璃体手术治疗的6例7眼的临床资料进行回顾分析。所有患眼均有不同程度的黄斑内界膜下积血,3眼伴少量玻璃体积血,均以玻璃体切除联合内界膜剥除术治疗。结果：患眼视力由术前的指数或手动提高至术后第1d的0.1～0.5,并在术后1mo内继续提高,术后3,6mo;1a随诊时仍维持稳定。随访期内未观察到严重并发症。结论：玻璃体切除联合内界膜剥除术是安全、有效的治疗严重Valsalva视网膜病变的方法。AIM： To evaluate the efficacy and safety of vitrectomy with internal limiting membrane （ILM） peeling as a treatment for Valsalva retinopathy. METHODS： Six cases （7 eyes） with Valsalva retinopathy were treated by vitrectomy surgery and their clinical documents were retrospectively analyzed. All eyes presented premacular sub-lLM hemorrhage, in which 3 eyes were with minor vitreous hemorrhage. Treatment was standard vitrectomy with ILM-peeling. RESULTS： Vision was improved from finger-counting or hand-motion preoperatively to 0.1-0.5 in all eyes at the first day after operation, increased gradually within 1 month and maintained stable at 3, 6 months and 1 year during the following up. There were no serious complications. CONCLUSION： Vitrectomy with ILM-peeling is a safe and effective alternative to conservative treatment or YAG laser membranotomy for treating selected cases of Valsalva retinopathy.

关 键 词：视网膜出血 外科学 玻璃体切除术 治疗效果 VALSALVA动作 

分 类 号：R779.6[医药卫生—眼科]